Hans De Loof

4.0k total citations · 2 hit papers
60 papers, 3.2k citations indexed

About

Hans De Loof is a scholar working on Molecular Biology, General Health Professions and Geriatrics and Gerontology. According to data from OpenAlex, Hans De Loof has authored 60 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in General Health Professions and 12 papers in Geriatrics and Gerontology. Recurrent topics in Hans De Loof's work include Pharmaceutical Practices and Patient Outcomes (12 papers), Medication Adherence and Compliance (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Hans De Loof is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (12 papers), Medication Adherence and Compliance (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Hans De Loof collaborates with scholars based in Belgium, United States and Uganda. Hans De Loof's co-authors include Jere P. Segrest, G.M. Anantharamaiah, Martin K. Jones, C.G. Brouillette, Jan G. Dohlman, Christie G. Brouillette, Nassrin Dashti, Guido R.Y. De Meyer, Stephen C. Harvey and Wim Martinet and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Hans De Loof

55 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function.

1992 739 citations Hans De Loof et al. profile →
Amphipathic helix motif: Classes and properties

1990 558 citations Hans De Loof et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans De Loof Belgium	17	1.8k	865	729	324	249	60	3.2k
Toshiyuki Sakaeda Japan	45	2.1k 1.2×	1.0k 1.2×	275 0.4×	312 1.0×	253 1.0×	220	7.1k
Kathrin Klein Germany	44	1.8k 1.0×	586 0.7×	584 0.8×	466 1.4×	126 0.5×	112	7.7k
Michael N. Oda United States	38	1.7k 1.0×	1.4k 1.6×	1.3k 1.8×	424 1.3×	518 2.1×	73	4.1k
Hitoshi Chiba Japan	31	1.5k 0.8×	514 0.6×	483 0.7×	181 0.6×	251 1.0×	232	3.4k
Dennis J. O’Kane United States	35	1.7k 1.0×	841 1.0×	490 0.7×	152 0.5×	127 0.5×	113	4.2k
Alan T. Remaley United States	34	1.1k 0.6×	706 0.8×	548 0.8×	379 1.2×	512 2.1×	117	3.6k
Kevin L. Duffin United States	43	1.9k 1.1×	578 0.7×	1.1k 1.6×	256 0.8×	490 2.0×	107	5.5k
Rex A. Parker United States	25	1.8k 1.0×	1.0k 1.2×	353 0.5×	409 1.3×	375 1.5×	45	4.0k
Richard B. Weinberg United States	31	861 0.5×	1.1k 1.3×	1.1k 1.4×	353 1.1×	79 0.3×	93	2.8k
Cristina Rodríguez‐Antona Spain	39	2.2k 1.2×	547 0.6×	500 0.7×	1.1k 3.4×	117 0.5×	137	6.0k

Countries citing papers authored by Hans De Loof

Since Specialization

Citations

This map shows the geographic impact of Hans De Loof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans De Loof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans De Loof more than expected).

Fields of papers citing papers by Hans De Loof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans De Loof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans De Loof. The network helps show where Hans De Loof may publish in the future.

Co-authorship network of co-authors of Hans De Loof

This figure shows the co-authorship network connecting the top 25 collaborators of Hans De Loof. A scholar is included among the top collaborators of Hans De Loof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans De Loof. Hans De Loof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meyer, Guido R.Y. De, et al.. (2025). Streamlining the quality assessment in medication reviews: a biased random sampling approach using BRANT-MERQS criteria. International Journal of Clinical Pharmacy. 47(3). 878–883.

Roth, Lynn, et al.. (2024). The role of large language models in self-care: a study and benchmark on medicines and supplement guidance accuracy. International Journal of Clinical Pharmacy. 47(4). 1001–1010. 4 indexed citations

García‐Cárdenas, Victoria, et al.. (2024). Medication Review: What’s in a Name and What Is It about?. SHILAP Revista de lepidopterología. 12(1). 39–39. 7 indexed citations

Steurbaut, Stéphane, et al.. (2024). Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitus. Frontiers in Pharmacology. 15. 1359568–1359568. 1 indexed citations

Boogaerts, Tim, Hans De Loof, Jan Saevels, et al.. (2023). Do the lockdown-imposed changes in a wastewater treatment plant catchment's socio-demographics impact longitudinal temporal trends in psychoactive pharmaceutical use?. The Science of The Total Environment. 876. 162342–162342. 9 indexed citations

Loof, Hans De, et al.. (2023). A quality improvement study of the implementation and initial results of a pragmatic clinical decision support system in the community pharmacy setting. International Journal of Clinical Pharmacy. 46(1). 141–149. 1 indexed citations

Steurbaut, Stéphane, et al.. (2023). Patient experiences and opinions on medication review: a qualitative study. International Journal of Clinical Pharmacy. 45(3). 650–658. 8 indexed citations

Loof, Hans De, et al.. (2023). Comprehensive Medication Management Services with a Holistic Point of View, a Scoping Review. SHILAP Revista de lepidopterología. 11(1). 37–37. 7 indexed citations

Loof, Hans De, Kris Van den Broeck, Kristel De Vliegher, et al.. (2022). Scoping review to identify strategies and interventions improving interprofessional collaboration and integration in primary care. BMJ Open. 12(10). e062111–e062111. 16 indexed citations

10.

Boogaerts, Tim, Catalina Dumitrascu, Lies Lahousse, et al.. (2022). Evaluating the impact of COVID-19 countermeasures on alcohol consumption through wastewater-based epidemiology: A case study in Belgium. Environment International. 170. 107559–107559. 16 indexed citations

11.

Loof, Hans De, Nathalie Moens, Véronique Verhoeven, et al.. (2021). Overprescribing of Topical Ocular Corticosteroids and Antibiotics in Out-of-Hours Primary Care in Belgium. Drug Healthcare and Patient Safety. Volume 13. 229–232. 6 indexed citations

12.

Boogaerts, Tim, et al.. (2021). Analytical method for the simultaneous determination of a broad range of opioids in influent wastewater: Optimization, validation and applicability to monitor consumption patterns. Talanta. 232. 122443–122443. 30 indexed citations

13.

Steurbaut, Stéphane, et al.. (2021). Qualitative study of medication review in Flanders, Belgium among community pharmacists and general practitioners. International Journal of Clinical Pharmacy. 43(5). 1173–1182. 16 indexed citations

14.

Colliers, Annelies, Jeroen De Man, Niels Adriaenssens, et al.. (2021). Antibiotic Prescribing Trends in Belgian Out-of-Hours Primary Care during the COVID-19 Pandemic: Observational Study Using Routinely Collected Health Data. Antibiotics. 10(12). 1488–1488. 16 indexed citations

15.

Meyer, Guido R.Y. De, et al.. (2019). Hormonal contraception without a prescription: opinions of pharmacists, general practitioners and gynaecologists in Flanders, Belgium. The European Journal of Contraception & Reproductive Health Care. 24(2). 85–96. 3 indexed citations

16.

Bastiaens, Hilde, et al.. (2018). Patient Perceptions of Electronic Prescriptions in Belgium: An Exploratory Policy Analysis. SHILAP Revista de lepidopterología. 6(4). 130–130. 8 indexed citations

17.

Pieters, Luc, et al.. (2018). Pilot Study on the Utility and Feasibility of a House-Call Checkup of the Medicine Cabinet. SHILAP Revista de lepidopterología. 6(3). 74–74. 3 indexed citations

18.

Fraeyman, Jessica, Veerle Foulon, Els Mehuys, et al.. (2016). Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium. Research in Social and Administrative Pharmacy. 13(1). 98–108. 16 indexed citations

19.

Marien, Koen M., Wim Martinet, Hans De Loof, et al.. (2015). Predictive tissue biomarkers for bevacizumab-containing therapy in metastatic colorectal cancer: an update. Expert Review of Molecular Diagnostics. 15(3). 399–414. 9 indexed citations

20.

Fraeyman, Jessica, Linda Symons, Hans De Loof, et al.. (2014). Medicine price awareness in chronic patients in Belgium. Health Policy. 119(2). 217–223. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact